Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S21 pseudogene 7 (RPS21P7) is a non-functional genetic sequence in the human genome classified as a pseudogene due to its similarity to the functional RPS21 gene, which encodes a component of the 40S ribosomal subunit responsible for protein synthesis. Pseudogenes like RPS21P7 arise from gene duplication or retrotransposition events and are typically not transcribed into functional proteins. There is no evidence of a direct biological or pathological function, drug interaction, or relevance as a biomarker for this pseudogene. Therefore, it is not considered a therapeutic or research target. For ribosomal protein S21 (RPS21), see the functional parent: "Ribosomal protein S21" (RPS21), which participates in protein synthesis as part of the small ribosomal subunit. For mitochondrial analogs, see MRPS21 (mitochondrial ribosomal protein S21) and its associated pseudogenes like MRPS21P7, which have similar non-functional status. RPS21P7 is a processed pseudogene of the ribosomal protein S21 family and does not encode an active protein or have any therapeutic target relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S21 pseudogene 7 (RPS21P7).